Seres Therapeutics, Inc. (MCRB)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 0.9000 |
| Open | 0.9100 |
| Bid | 0.9145 x 100 |
| Ask | 0.9531 x 600 |
| Day's range | 0.8701 - 1.3200 |
| 52-week range | 0.5400 - 3.2400 |
| Volume | |
| Avg. volume | 3,831,109 |
| Market cap | 145.357M |
| Beta (5Y monthly) | 2.01 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.1900 |
| Earnings date | 31 Oct 2024 - 04 Nov 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 3.47 |
ZacksAfter Plunging -22.45% in 4 Weeks, Here's Why the Trend Might Reverse for Seres Therapeutics (MCRB)
The heavy selling pressure might have exhausted for Seres Therapeutics (MCRB) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
ZacksBears are Losing Control Over Seres Therapeutics (MCRB), Here's Why It's a 'Buy' Now
Seres Therapeutics (MCRB) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.
- Thomson Reuters StreetEvents
Q2 2024 Seres Therapeutics Inc Earnings Call
Q2 2024 Seres Therapeutics Inc Earnings Call
© 2024 Yahoo. All rights reserved.